Design Therapeutics, Inc. (DSGN) stock
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.84−0.08 (-0.81%)
Close on Nov 17, 2026Market cap $615.80MP/E –Yield –
Design Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Design Therapeutics's profit margin for the twelve months ending Dec 31, 2020 was -3663.7%. For fiscal 2020 it was -3663.7%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -3663.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -11681.8% | – |
| Q3 FY2020 | Sep 30, 2020 | -11600.0% | – |
| Q2 FY2020 | Jun 30, 2020 | -4651.6% | – |
| Q1 FY2020 | Mar 31, 2020 | -466.9% | – |
See a number that looks wrong?